De Pardieu has advised 21 Invest France on the capital reorganization of PLG, a global expert in regulatory affairs and compliance consulting for the healthcare industry.
Serving more than 1,000 clients ranging from pharmaceutical companies, biotech and medtech companies, PLG covers the entire lifecycle of pharmaceutical products, from development to post-marketing vigilance, across more than 150 countries. Thanks to this transaction, PLG will pursue its strategic project and further accelerate its development.
In connection with this transaction, in addition to its management team, which is reinvesting significantly, PLG will be jointly controlled by Oakley Capital and 21 Invest France, which is reinvesting through its sixth fund vintage and newly established continuation fund. This dedicated vehicle was raised with the support of Evercore PCA as financial advisor, and Eurazeo and Hayfin as lead investors. Other investors are joining in syndication including Arcano, CA Indosuez Wealth Management and Vintage Strategies at Goldman Sachs Alternatives. The transaction was completed on 23 May 2024.